|
Volumn 111, Issue 6, 2009, Pages 1180-1182
|
Perioperative comparative effectiveness research: An opportunity calling
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANALGESIC AGENT;
ANESTHETIC AGENT;
APROTININ;
INSULIN;
OPIATE;
ANESTHESIA;
BETA ADRENERGIC RECEPTOR BLOCKING;
BLOOD;
CLINICAL DECISION MAKING;
CLINICAL EFFECTIVENESS;
CLINICAL PRACTICE;
CLINICAL RESEARCH;
EDITORIAL;
GLUCOSE BLOOD LEVEL;
HEALTH CARE COST;
HEALTH CARE DELIVERY;
HIGH RISK PATIENT;
HOSPITAL INFECTION;
HOSPITALIZATION;
HUMAN;
HYPERGLYCEMIA;
INSULIN TREATMENT;
INTENSIVE CARE UNIT;
LOW BACK PAIN;
MORBIDITY;
MORTALITY;
PATIENT SAFETY;
PERIOPERATIVE PERIOD;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
SURGICAL RISK;
TOTAL KNEE REPLACEMENT;
TRANSFORMED MIGRAINE;
KNEE ARTHROPLASTY;
MEDICAL INFORMATICS;
NATIONAL HEALTH ORGANIZATION;
NOTE;
POLICY;
POSTOPERATIVE PAIN;
RESEARCH;
TREATMENT OUTCOME;
UNITED STATES;
AMERICAN RECOVERY AND REINVESTMENT ACT;
ANESTHESIA;
ARTHROPLASTY, REPLACEMENT, KNEE;
NATIONAL INSTITUTES OF HEALTH (U.S.);
PAIN, POSTOPERATIVE;
PUBLIC POLICY;
RESEARCH;
TREATMENT OUTCOME;
UNITED STATES;
|
EID: 73449103242
PISSN: 00033022
EISSN: 15281175
Source Type: Journal
DOI: 10.1097/ALN.0b013e3181bfabb4 Document Type: Editorial |
Times cited : (10)
|
References (12)
|